Target Price | $265.20 |
Price | $159.28 |
Potential | 66.50% |
Number of Estimates | 30 |
30 Analysts have issued a price target Atlassian 2026 . The average Atlassian target price is $265.20. This is 66.50% higher than the current stock price. The highest price target is $441.00 176.87% , the lowest is $213.11 33.80% . | |
A rating was issued by 36 analysts: 28 Analysts recommend Atlassian to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Atlassian stock has an average upside potential 2026 of 66.50% . Most analysts recommend the Atlassian stock at Purchase. |
33 Analysts have issued a sales forecast Atlassian 2026 . The average Atlassian sales estimate is $6.3b . This is 20.41% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $6.7b 27.84% , the lowest is $5.8b 11.98% .
This results in the following potential growth metrics:
2025 | $5.2b | 19.66% |
---|---|---|
2026 | $6.3b | 20.41% |
2027 | $7.5b | 19.03% |
2028 | $8.8b | 17.22% |
2029 | $10.2b | 16.39% |
2030 | $11.9b | 16.92% |
2031 | $13.7b | 15.20% |
2032 | $15.7b | 14.36% |
14 Analysts have issued an Atlassian EBITDA forecast 2026. The average Atlassian EBITDA estimate is $1.6b . This is 1,510.99% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.9b 1,717.26% , the lowest is $1.5b 1,382.72% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $-115m | 10.60% |
---|---|---|
2026 | $1.6b | 1,510.99% |
2027 | $2.0b | 23.59% |
2028 | $2.1b | 6.26% |
2029 | $2.5b | 16.37% |
2025 | -2.21% | 7.57% |
---|---|---|
2026 | 25.92% | 1,271.61% |
2027 | 26.92% | 3.86% |
2028 | 24.40% | 9.36% |
2029 | 24.40% | 0.00% |
32 Atlassian Analysts have issued a net profit forecast 2026. The average Atlassian net profit estimate is $1.1b . This is 541.11% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.4b 654.08% , the lowest is $1.0b 490.86% .
This results in the following potential growth metrics and future Net Margins:
2025 | $-257m | 14.58% |
---|---|---|
2026 | $1.1b | 541.11% |
2027 | $1.4b | 21.96% |
2028 | $1.6b | 15.82% |
2029 | $2.0b | 21.96% |
2030 | $2.8b | 43.31% |
2031 | $3.5b | 25.48% |
2032 | $4.3b | 23.97% |
2025 | -4.92% | 28.62% |
---|---|---|
2026 | 18.03% | 466.32% |
2027 | 18.47% | 2.44% |
2028 | 18.25% | 1.19% |
2029 | 19.13% | 4.82% |
2030 | 23.45% | 22.58% |
2031 | 25.54% | 8.91% |
2032 | 27.68% | 8.38% |
32 Analysts have issued a Atlassian forecast for earnings per share. The average Atlassian EPS is $4.31 . This is 535.35% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.42 647.47% , the lowest is $3.82 485.86% .
This results in the following potential growth metrics and future valuations:
2025 | $-0.98 | 15.52% |
---|---|---|
2026 | $4.31 | 539.80% |
2027 | $5.26 | 22.04% |
2028 | $6.09 | 15.78% |
2029 | $7.43 | 22.00% |
2030 | $10.65 | 43.34% |
2031 | $13.36 | 25.45% |
2032 | $16.56 | 23.95% |
Current | -160.89 | 29.68% |
---|---|---|
2026 | 36.93 | 122.95% |
2027 | 30.28 | 18.01% |
2028 | 26.14 | 13.67% |
2029 | 21.44 | 17.98% |
2030 | 14.96 | 30.22% |
2031 | 11.92 | 20.32% |
2032 | 9.62 | 19.30% |
Based on analysts' sales estimates for 2026, the Atlassian stock is valued at an EV/Sales of 6.37 and an P/S ratio of 6.68 .
This results in the following potential growth metrics and future valuations:
Current | 7.67 | 5.66% |
---|---|---|
2026 | 6.37 | 16.99% |
2027 | 5.35 | 15.99% |
2028 | 4.56 | 14.69% |
2029 | 3.92 | 14.08% |
2030 | 3.35 | 14.47% |
2031 | 2.91 | 13.19% |
2032 | 2.55 | 12.55% |
Current | 8.04 | 4.71% |
---|---|---|
2026 | 6.68 | 16.95% |
2027 | 5.61 | 15.99% |
2028 | 4.79 | 14.69% |
2029 | 4.11 | 14.08% |
2030 | 3.52 | 14.47% |
2031 | 3.05 | 13.19% |
2032 | 2.67 | 12.56% |
Analyst | Rating | Action | Date |
---|---|---|---|
Stephens & Co. |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Aug 11 2025 |
Raymond James |
Outperform
➜
Outperform
|
Unchanged | Aug 08 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Aug 08 2025 |
Mizuho |
Outperform
➜
Outperform
|
Unchanged | Aug 08 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Aug 08 2025 |
Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Aug 08 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 21 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Stephens & Co.:
Equal-Weight
➜
Equal-Weight
|
Aug 11 2025 |
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Aug 08 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Aug 08 2025 |
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Aug 08 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Aug 08 2025 |
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Aug 08 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.